Implanon Birth Control Implant Lawsuit | 2026 Latest Updates

The Implanon birth control implant and its successor Nexplanon can migrate from the arm, making removal difficult. Some women claim an implant moved out of place and went missing. A case report describes one that reached a pulmonary artery. No injury class action or MDL over Implanon or Nexplanon has been identified. The one court action tied to Nexplanon is an investor class action against Organon, announced July 9, 2025. That suit alleges misleading sales statements, not injuries. A moved implant can be hard to remove, and imaging may be needed to find it, according to the label. Women who cannot feel an implant in the arm may be affected.

Latest Implanon Birth Control Implant Lawsuit Updates

July 9, 2025: Investors File Securities Class Action Against Organon

On July 9, 2025, a securities class action against Organon was announced [1]. It covers investors who bought Organon securities between November 3, 2022 and April 30, 2025. The case is Lerner v. Organon & Co., No. 25-cv-12983, in federal court in New Jersey. It alleges misleading Nexplanon sales statements. It is not an injury case.

September 19, 2024: Case Report Describes Implant in Pulmonary Artery

On September 19, 2024, the Open Journal of Obstetrics and Gynecology published a case report by Sissoko et al. [2]. It describes a 36-year-old woman in Bamako, Mali. A chest X-ray and CT scan showed her progestin implant had migrated into a branch of the left pulmonary artery.

October 8, 2018: Circa Investigation Finds Nexplanon Migration

On October 8, 2018, Joce Sterman and Alex Brauer of Circa wrote that Nexplanon can migrate. The article was posted by the National Center for Health Research [3]. Circa counted at least 400 FDA reports of “device dislocation” in six years. The FDA told Circa some of those reports could be duplicates.

June 25, 2005: Dutch Court Awards Damages for Unintended Pregnancies

On June 25, 2005, the BMJ reported a ruling by a court in Holland [4]. The court found that 15 women who became pregnant despite using Implanon were entitled to damages for unintended pregnancy. Whether Organon or the doctors are liable was left open. Organon said it believed Implanon, if inserted correctly, is a safe and reliable contraceptive. The ruling concerned contraceptive failure, not migration.

What Is the Implanon Birth Control Implant?

The FDA-approved label on DailyMed says Nexplanon is “a progestin indicated for prevention of pregnancy in women of reproductive potential for up to 5 years” [5]. The same label calls the earlier product “the non-radiopaque etonogestrel implant (IMPLANON).” So Implanon is the older implant and Nexplanon is the current one. This page covers both.

Who May Be Affected?

Women who had an Implanon or Nexplanon implant placed in the upper arm may be affected. Circumstances to match include an implant that can no longer be felt and a removal that needed imaging or surgery. The label warns: “Insertion and removal complications: Pain, paresthesia, bleeding, hematoma, scarring, infection, or migration to vasculature, including pulmonary vessels, may occur.” It also says implant removal “may be difficult or impossible if the implant … has migrated.” Without a filed injury case, whether you have a claim needs an individual legal review.

Reported Injuries or Damages

Injury claims allege the implant migrated and could not be found or removed. A 2018 WLOS report said that in one ongoing lawsuit, women claim the Implanon implant “spontaneously moved and couldn’t be found or removed” [6]. That lawsuit is not identified. The claims remain allegations, not findings. Of the FDA adverse reports Circa reviewed, more than 100 were listed as serious. Adverse reports are not proof that the implant caused every event. In the 2024 case report, cardiovascular surgeons chose therapeutic abstention. It describes a single case.

Recall and Regulatory Background

The FDA has not recalled Implanon or Nexplanon. In 2016, Merck changed the Nexplanon label. Circa described it as “adding in new language to better warn about the possibility that the implant may migrate.” Merck also sent a letter to health care practitioners. The current label carries the migration warning, and Nexplanon was made radiopaque so it can be seen on X-ray.

Evidence to Preserve

Keep these records and items if an Implanon or Nexplanon implant moved or was hard to remove:

• Medical records of the insertion and removal, and notes on any missed or failed removal attempts.
• Imaging reports such as X-ray, ultrasound, MRI or CT. The label says imaging may be needed to find the implant.
• The implant’s product and lot information from your patient card or chart.
• Photographs or video of your arm and of the removal scar, if you have them.
• Pharmacy and appointment records, along with your own notes on symptoms as they happened.
• Any messages with the clinic about the implant, its placement or its removal.

Filing Deadlines

Time limits for injury claims are set by the state where you live. The clock also depends on when your implant problem and its diagnosis occurred. Some states count from the date of diagnosis. Missing a deadline can end a claim, even one with strong facts behind it. Check with a lawyer promptly. A lawyer can tell you which state deadline applies to you and when the clock started for your injury.

Frequently Asked Questions

Is There an Implanon Birth Control Implant Lawsuit?

The only Implanon birth control implant lawsuit tied to Nexplanon is an investor suit against Organon. It alleges Nexplanon “faced a higher risk of loss of exclusivity and price erosion” than implied and that sales would not reach $1 billion by the end of fiscal year 2025.

Can the Implanon Implant Migrate in the Body?

Yes, the Implanon implant can migrate in the body. The label says migration usually involves minor movement but may leave the implant not palpable. If it is not found in the arm, the label suggests imaging of the chest.

Has Implanon Been Recalled?

No, Implanon has not been recalled. The Nexplanon label on DailyMed was last revised in May 2026 and still carries the migration warning for the implant, including migration to the pulmonary vessels.

What Does the Research Say About Implanon Migration?

The research on Implanon migration includes an FDA article that, as described by Circa, details 20 previously unpublished severe Nexplanon cases through 2015, including women who needed surgery after the implant migrated.

Who Makes the Implanon Implant?

Organon makes the Implanon implant and Nexplanon, and the label lists Organon USA LLC. Merck & Co. was the marketer in 2018. Merck told Circa it is committed to safe birth control options, including Nexplanon.

What Symptoms Are Linked to an Implant in the Pulmonary Vessels?

Symptoms linked to an implant in the pulmonary vessels include chest pain, dyspnea, cough or hemoptysis, according to the label. The label adds that surgical interventions may be necessary to remove such implants.

References

1. https://www.prnewswire.com/news-releases/extended-class-period-alert-organon–co-investors-with-substantial-losses-have-opportunity-to-lead-securities-class-action-lawsuit-302500677.html
2. https://www.scirp.org/pdf/ojog2024149_111433468.pdf
3. https://www.center4research.org/nexplanon-prevents-pregnancy-goes-missing/
4. https://pmc.ncbi.nlm.nih.gov/articles/PMC558449
5. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487f8a62-e142-457c-97cc-2e398fde7594
6. https://wlos.com/news/nation-world/popular-birth-control-implant-has-potential-go-missing-in-your-body